NASDAQ : CSBR
Champions Oncology, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 4.81 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 66.95M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Champions Oncology, Inc. (CSBR) reported revenue of 60.66M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year May - April; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 60.66M | 59.42M | 56.94M | 50.16M | 53.87M | 49.11M |
| Cost of Revenue | 30.44M | 30.90M | 28.39M | 29.40M | 29.53M | 23.63M |
| Gross Profit | 30.22M | 28.52M | 28.55M | 20.75M | 24.34M | 25.48M |
| Selling, General & Admin | 21.81M | 20.47M | 16.88M | 18.13M | 17.24M | 15.50M |
| Research & Development | 9.35M | 9.08M | 6.83M | 9.54M | 11.54M | 9.37M |
| Operating Expenses | 31.15M | 29.55M | 23.71M | 27.68M | 28.79M | 24.87M |
| Operating Income | -931.00K | -1.03M | 4.85M | -6.92M | -4.45M | 607.00K |
| Interest Expense | -28.00K | |||||
| Interest & Investment Income | 92.00K | |||||
| Currency Exchange Gain (Loss) | -16.00K | -11.00K | -24.00K | |||
| Other Non Operating Income (Expenses) | 130.00K | 211.00K | 73.00K | |||
| EBT Excluding Unusual Items | -801.00K | -818.00K | 4.92M | -6.87M | -4.46M | 583.00K |
| Gain (Loss) on Sale of Assets | -91.00K | -111.00K | -293.00K | -435.00K | ||
| Asset Writedown | -807.00K | |||||
| Pretax Income | -892.00K | -929.00K | 4.63M | -7.31M | -5.27M | 583.00K |
| Income Tax Expense | 243.00K | 246.00K | -75.00K | -32.00K | 68.00K | 35.00K |
| Net Income | -1.14M | -1.18M | 4.70M | -7.28M | -5.33M | 548.00K |
| Net Income to Common | -1.14M | -1.18M | 4.70M | -7.28M | -5.33M | 548.00K |
| Shares Outstanding (Basic) | 13.86M | 13.83M | 13.66M | 13.55M | 13.54M | 13.20M |
| Shares Outstanding (Diluted) | 13.86M | 13.83M | 14.27M | 13.55M | 13.54M | 14.16M |
| EPS (Basic) | -0.08 | -0.08 | 0.34 | -0.54 | -0.39 | 0.04 |
| EPS (Diluted) | -0.08 | -0.08 | 0.33 | -0.54 | -0.39 | 0.04 |
| Free Cash Flow | -6.14M | -5.04M | 7.00M | -6.97M | 1.10M | 4.11M |
| Free Cash Flow Per Share | -0.44 | -0.36 | 0.49 | -0.52 | 0.08 | 0.29 |
| Gross Margin | 49.82% | 48.00% | 50.15% | 41.38% | 45.18% | 51.88% |
| Operating Margin | -1.54% | -1.73% | 8.51% | -13.80% | -8.26% | 1.24% |
| Profit Margin | -1.87% | -1.98% | 8.25% | -14.51% | -9.90% | 1.12% |
| Free Cash Flow Margin | -10.12% | -8.48% | 12.29% | -13.90% | 2.04% | 8.38% |
| EBITDA | 402.00K | 348.00K | 6.49M | -5.05M | -2.83M | 2.23M |
| EBITDA Margin | 0.66% | 0.59% | 11.39% | -10.08% | -5.26% | 4.55% |
| D&A For EBITDA | 1.33M | 1.38M | 1.64M | 1.87M | 1.62M | 1.63M |
| EBIT | -931.00K | -1.03M | 4.85M | -6.92M | -4.45M | 607.00K |
| EBIT Margin | -1.54% | -1.73% | 8.51% | -13.80% | -8.26% | 1.24% |
| Effective Tax Rate | 6.00% |
Balance sheet
Fiscal year May - April; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.36M | 4.87M | 9.79M | 2.62M | 10.12M | 9.01M |
| Cash & Short-Term Investments | 4.36M | 4.87M | 9.79M | 2.62M | 10.12M | 9.01M |
| Receivables | 13.60M | 13.18M | 11.20M | 9.53M | 8.01M | 9.51M |
| Prepaid Expenses | 1.33M | 1.17M | 1.37M | 1.50M | 1.33M | 1.14M |
| Total Current Assets | 19.29M | 19.22M | 22.36M | 13.64M | 19.46M | 19.66M |
| Property, Plant & Equipment | 13.46M | 7.22M | 9.46M | 11.97M | 14.50M | 15.36M |
| Goodwill | 335.00K | 335.00K | 335.00K | 335.00K | 335.00K | 335.00K |
| Other Long-Term Assets | 201.00K | 212.00K | 196.00K | 185.00K | 15.00K | 15.00K |
| Total Assets | 33.29M | 26.99M | 32.34M | 26.13M | 34.31M | 35.38M |
| Accounts Payable | 5.63M | 6.90M | 4.25M | 5.80M | 5.33M | 2.87M |
| Accrued Expenses | 2.68M | 2.59M | 2.56M | 2.16M | 2.27M | 2.41M |
| Current Portion of Leases | 869.00K | 1.60M | 1.61M | 1.34M | 1.21M | 1.05M |
| Current Unearned Revenue | 9.55M | 8.83M | 15.44M | 12.09M | 12.78M | 11.07M |
| Other Current Liabilities | 150.00K | 145.00K | 72.00K | |||
| Total Current Liabilities | 18.73M | 19.92M | 23.85M | 21.54M | 21.73M | 17.48M |
| Long-Term Leases | 10.10M | 3.00M | 4.72M | 6.09M | 7.39M | 8.41M |
| Other Long-Term Liabilities | 401.00K | 551.00K | 391.00K | |||
| Total Liabilities | 28.83M | 22.92M | 28.57M | 28.04M | 29.68M | 26.28M |
| Common Stock | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K |
| Additional Paid-In Capital | 86.08M | 85.70M | 84.36M | 83.38M | 82.01M | 81.06M |
| Retained Earnings | -81.49M | -81.07M | -79.89M | -84.59M | -77.32M | -71.98M |
| Treasury Stock | -708.00K | -708.00K | -708.00K | -708.00K | -74.00K | |
| Total Common Equity | 3.89M | 3.94M | 3.77M | -1.90M | 4.64M | 9.10M |
| Minority Interest | 567.00K | 129.00K | ||||
| Shareholders' Equity | 4.46M | 4.07M | 3.77M | -1.90M | 4.64M | 9.10M |
| Total Liabilities & Equity | 33.29M | 26.99M | 32.34M | 26.13M | 34.31M | 35.38M |
| Total Debt | 10.97M | 4.60M | 6.33M | 7.43M | 8.60M | 9.47M |
| Net Cash (Debt) | -6.61M | 274.00K | 3.46M | -4.81M | 1.52M | -459.00K |
| Net Cash Per Share | -0.48 | 0.02 | 0.24 | -0.36 | 0.11 | -0.03 |
| Filing Date Shares Outstanding | 13.92M | 13.89M | 13.78M | 13.59M | 13.46M | 13.52M |
| Total Common Shares Outstanding | 13.92M | 13.89M | 13.78M | 13.59M | 13.54M | 13.52M |
| Working Capital | 563.00K | -703.00K | -1.50M | -7.90M | -2.28M | 2.19M |
| Book Value Per Share | 0.28 | 0.28 | 0.27 | -0.14 | 0.34 | 0.67 |
| Tangible Book Value | 3.56M | 3.60M | 3.44M | -2.24M | 4.30M | 8.76M |
| Tangible Book Value Per Share | 0.26 | 0.26 | 0.25 | -0.16 | 0.32 | 0.65 |
| Machinery | 13.63M | 12.96M | 12.73M | 12.90M | 11.74M | 9.82M |
| Construction In Progress | 116.00K | 210.00K | 124.00K | 3.00K | 1.08M | 181.00K |
| Leasehold Improvements | 361.00K | 361.00K | 317.00K | 317.00K | 111.00K | 111.00K |
Cash flow statement
Fiscal year May - April; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -1.14M | -1.18M | 4.70M | -7.28M | -5.33M | 548.00K |
| Depreciation & Amortization | 1.33M | 1.38M | 1.64M | 1.87M | 1.62M | 1.63M |
| Other Amortization | 630.00K | |||||
| Loss (Gain) From Sale of Assets | 91.00K | 111.00K | 293.00K | 435.00K | -4.00K | |
| Asset Writedown & Restructuring Costs | 807.00K | |||||
| Stock-Based Compensation | 1.79M | 1.24M | 654.00K | 1.12M | 864.00K | 912.00K |
| Provision & Write-off of Bad Debts | 47.00K | 28.00K | -272.00K | 476.00K | 195.00K | 292.00K |
| Other Operating Activities | 1.35M | 1.37M | 991.00K | 1.07M | 952.00K | 786.00K |
| Change in Accounts Receivable | -4.17M | -2.00M | -1.44M | -1.99M | 1.31M | -2.82M |
| Change in Accounts Payable | 722.00K | 2.56M | -1.75M | 465.00K | 2.46M | 974.00K |
| Change in Unearned Revenue | -4.88M | -6.62M | 3.35M | -683.00K | 1.71M | 4.82M |
| Change in Other Net Operating Assets | -714.00K | -1.36M | -785.00K | -1.61M | -1.24M | -635.00K |
| Operating Cash Flow | -5.56M | -4.47M | 7.39M | -6.14M | 3.97M | 6.50M |
| Capital Expenditures | -573.00K | -564.00K | -389.00K | -836.00K | -2.87M | -2.38M |
| Sale of Property, Plant & Equipment | 24.00K | 24.00K | ||||
| Investing Cash Flow | -549.00K | -540.00K | -389.00K | -836.00K | -2.87M | -2.38M |
| Long-Term Debt Repaid | -135.00K | -150.00K | -146.00K | |||
| Net Debt Issued (Repaid) | -116.00K | -135.00K | -150.00K | -146.00K | ||
| Issuance of Common Stock | 262.00K | 234.00K | 320.00K | 253.00K | 85.00K | 207.00K |
| Repurchase of Common Stock | -634.00K | -74.00K | ||||
| Financing Cash Flow | 146.00K | 99.00K | 170.00K | -527.00K | 11.00K | 207.00K |
| Net Cash Flow | -5.97M | -4.91M | 7.17M | -7.50M | 1.11M | 4.32M |
| Free Cash Flow | -6.14M | -5.04M | 7.00M | -6.97M | 1.10M | 4.11M |
| Free Cash Flow Margin | -10.12% | -8.48% | 12.29% | -13.90% | 2.04% | 8.38% |
| Free Cash Flow Per Share | -0.44 | -0.36 | 0.49 | -0.52 | 0.08 | 0.29 |
| Levered Free Cash Flow | -5.49M | -4.29M | 5.42M | -4.20M | 2.88M | 3.86M |
| Unlevered Free Cash Flow | -5.49M | -4.29M | 5.42M | -4.18M | 2.88M | 3.86M |
| Change in Working Capital | -9.04M | -7.42M | -621.00K | -3.82M | 4.24M | 2.34M |
Ratios
Fiscal year May - April; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 66.95M | 82.77M | 98.00M | 65.93M | 66.71M | 103.85M |
| Enterprise Value | 73.56M | 80.73M | 101.49M | 69.20M | 63.93M | 104.78M |
| Last Close Price | 4.81 | 5.96 | 7.15 | 4.85 | 4.92 | 7.68 |
| PE Ratio | 20.85 | 189.51 | ||||
| Forward PE | 114.60 | 119.17 | 64.10 | 43.81 | 42.95 | |
| PS Ratio | 1.10 | 1.39 | 1.72 | 1.31 | 1.24 | 2.12 |
| PB Ratio | 17.20 | 20.34 | 25.98 | -34.65 | 14.39 | 11.42 |
| P/TBV Ratio | 18.82 | 22.96 | 28.51 | 15.51 | 11.85 | |
| P/FCF Ratio | 14.01 | 60.64 | 25.25 | |||
| P/OCF Ratio | 13.27 | 16.80 | 15.98 | |||
| PEG Ratio | 4.27 | 4.27 | 4.27 | 2.92 | 2.86 | |
| EV/Sales Ratio | 1.21 | 1.36 | 1.78 | 1.38 | 1.19 | 2.13 |
| EV/EBITDA Ratio | 182.99 | 231.99 | 15.65 | 46.90 | ||
| EV/EBIT Ratio | 20.94 | 172.62 | ||||
| EV/FCF Ratio | 14.51 | 58.12 | 25.48 | |||
| Debt / Equity Ratio | 2.46 | 1.13 | 1.68 | -3.90 | 1.85 | 1.04 |
| Debt / EBITDA Ratio | 5.02 | 2.16 | 0.77 | 2.29 | ||
| Debt / FCF Ratio | 0.90 | 7.82 | 2.30 | |||
| Net Debt / Equity Ratio | 1.48 | -0.07 | -0.92 | -2.53 | -0.33 | 0.05 |
| Net Debt / EBITDA Ratio | 16.45 | -0.79 | -0.53 | -0.95 | 0.54 | 0.20 |
| Net Debt / FCF Ratio | -1.08 | 0.05 | -0.49 | -0.69 | -1.38 | 0.11 |
| Asset Turnover | 1.90 | 2.00 | 1.95 | 1.66 | 1.55 | 1.56 |
| Quick Ratio | 0.96 | 0.91 | 0.88 | 0.56 | 0.83 | 1.06 |
| Current Ratio | 1.03 | 0.96 | 0.94 | 0.63 | 0.90 | 1.12 |
| Return on Equity (ROE) | -28.38% | -29.97% | 503.05% | -532.46% | -77.70% | 6.63% |
| Return on Assets (ROA) | -1.82% | -2.17% | 10.36% | -14.31% | -7.98% | 1.21% |
| Return on Invested Capital (ROIC) | -12.53% | -27.12% | -179.58% | -70.22% | 5.21% | |
| Return on Capital Employed (ROCE) | -6.40% | -14.60% | 57.10% | -150.80% | -35.40% | 3.40% |
| Earnings Yield | -1.70% | -1.42% | 4.80% | -11.04% | -8.00% | 0.53% |
| FCF Yield | -9.17% | -6.08% | 7.14% | -10.58% | 1.65% | 3.96% |
| Buyback Yield / Dilution | 2.42% | 3.04% | -5.31% | -0.04% | 4.37% | 2.84% |